The Interventional Cardiology and Peripheral Vascular Devices Market is Expected to Reach USD 31.47 Billion by 2021

“Interventional Cardiology & Peripheral Vascular Devices Market (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) – Forecasts to 2021”

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the interventional cardiology and peripheral vascular devices market, along with revenue estimates & forecasts and market share analysis.

Browse through market data tables and the in-depth ToC of the Global Interventional Cardiology and Peripheral Vascular Devices Market (2016–2021)

http://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

The global interventional cardiology and peripheral vascular devices market is expected to reach USD 31.47 billion by 2021 from USD 21.83 billion in 2016, at a CAGR of 7.1% from 2016 to 2021. Rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive procedures, and technological advancements are the major factors driving the growth of this market.

On the basis of product, the interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. In 2016, the angioplasty stents segment is expected to account for the largest share of the market. High growth in this segment can be attributed to rising number of regulatory approvals, technological advancements, and increasing initiatives by companies for new product launches.

Get The PDF Brochure For This Report@

http://www.marketsandmarkets.com/pdfdownload.asp?id=548

On the basis of type, the angioplasty stent market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. In 2016, the drug-eluting stents segment is expected to account for the largest share primarily due to the increasing number of regulatory approvals and technological advancements.

On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the angiography catheters segment is expected to account for the largest share of the market.

On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is expected to account for the largest share primarily due to the rising incidence of smoking and hypertension.

On the basis of region, the global interventional cardiology and peripheral vascular devices market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. Growth in this regional segment is driven by factors such as the rising prevalence of cardiovascular diseases, increasing number of conferences & symposia, and increasing focus of major players on the Asian market.

Some of the major players operating in the interventional cardiology and peripheral vascular devices market are Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), Cordis Corporation (U.S.), C.R. Bard, Inc. (U.S.), Medtronic plc (U.S.), and Terumo Corporation (Japan).